NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 39 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $47,889,000 | +5.6% | 36,316,000 | +0.6% | 0.42% | +11.7% |
| Q4 2021 | $45,348,000 | -7.0% | 36,116,000 | -1.2% | 0.38% | -17.9% |
| Q3 2021 | $48,765,000 | +30.4% | 36,542,000 | +31.4% | 0.46% | +30.8% |
| Q2 2021 | $37,405,000 | -0.6% | 27,806,000 | -0.0% | 0.35% | +28.1% |
| Q1 2021 | $37,627,000 | +21.1% | 27,818,000 | +24.3% | 0.27% | +28.0% |
| Q4 2020 | $31,068,000 | -8.4% | 22,388,000 | -8.7% | 0.21% | -7.0% |
| Q3 2020 | $33,931,000 | -17.5% | 24,531,000 | -0.4% | 0.23% | -29.9% |
| Q2 2020 | $41,149,000 | +30.0% | 24,627,000 | +0.1% | 0.33% | +11.9% |
| Q1 2020 | $31,641,000 | -16.3% | 24,612,000 | +0.0% | 0.29% | +12.7% |
| Q4 2019 | $37,782,000 | -34.0% | 24,608,000 | -41.0% | 0.26% | -25.5% |
| Q3 2019 | $57,234,000 | +93.6% | 41,733,000 | +85.8% | 0.35% | +72.8% |
| Q2 2019 | $29,557,000 | +1.8% | 22,460,000 | +4.7% | 0.20% | -4.3% |
| Q1 2019 | $29,043,000 | +12.9% | 21,460,000 | -0.2% | 0.21% | +1.0% |
| Q4 2018 | $25,718,000 | -30.3% | 21,509,000 | -0.5% | 0.21% | -25.9% |
| Q3 2018 | $36,877,000 | +19.2% | 21,609,000 | +1.0% | 0.28% | +31.8% |
| Q2 2018 | $30,931,000 | – | 21,402,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 45,447,000 | $60,497,000 | 1.31% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,366,000 | $5,924,000 | 0.54% |
| Aequim Alternative Investments LP | 7,609,000 | $10,088,000 | 0.43% |
| MACKAY SHIELDS LLC | 27,806,000 | $37,405,000 | 0.35% |
| Weiss Asset Management LP | 10,000,000 | $13,290,000 | 0.33% |
| WOLVERINE ASSET MANAGEMENT LLC | 13,230,000 | $17,541,000 | 0.13% |
| Polar Asset Management Partners Inc. | 7,500,000 | $9,942,000 | 0.10% |
| LORD, ABBETT & CO. LLC | 22,141,000 | $29,732,000 | 0.07% |
| Calamos Advisors LLC | 7,500,000 | $9,967,000 | 0.05% |
| D. E. Shaw & Co., Inc. | 39,270,000 | $52,046,000 | 0.04% |